Undiagnosed Diabetes: Identifying the Community Paths to Type 2 Diabetes Diagnostic Testing
Loading...
Author/Creator
Date
2020-12-16
Type of Work
Department
Program
Citation of Original Publication
Sarah Chard and others, Undiagnosed Diabetes: Identifying the Community Paths to Type 2 Diabetes Diagnostic Testing, Innovation in Aging, Volume 4, Issue Supplement_1, 2020, Page 376, https://doi.org/10.1093/geroni/igaa057.1211
Rights
This item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author.
Attribution 4.0 International (CC BY 4.0)
Attribution 4.0 International (CC BY 4.0)
Subjects
Abstract
Over seven million U.S. adults are estimated to have undiagnosed diabetes and are at heightened risk of diabetes
complications and poorer long-term glycemic control. Key to
addressing undiagnosed diabetes is identifying how persons
encounter diabetes testing in everyday life and the contextual
factors that lead to consulting a health care provider. As part
of the NIA-funded Subjective Experience of Diabetes Study
we examined the pathways through which community-living
African-American and non-Hispanic White older adults with
type 2 diabetes (T2D) (N=75) received their T2D diagnosis.
Systematic, thematic analyses using ATLAS.ti reveals three
primary routes to diabetes diagnosis: diagnosis through continuity of primary care, diagnosis through happenstance
testing, and diagnosis following the exacerbation of symptoms. While diagnosis as part of routine care was the least
reported (N=13), participants’ accounts suggest diagnosis in
primary care validates the patient-provider relationship and
provides an occasion to calmly establish a treatment plan.
More frequently, however, diagnosis occurs through fortuitous encounters with glucose tests, e.g., through work or
community research projects (N=15) or after symptoms become alarming and disrupt daily life (N=47). Participants’
experiences in these latter two categories reveal the critical
role of insurance and social prompts in the decision to consult a clinical provider regarding symptoms. At the same
time, the abundance of over-the-counter therapies treating
conditions commonly found early in the emergence of diabetes can delay clinical follow up. These findings highlight
the importance of social prompts and community-based
testing in the fight to reduce undiagnosed diabetes.